PTPRC and neoplasm: CD45+ erythroblasts have been shown to accumulate in the spleens of tumor-bearing mice and exert immunosuppressive effects on CD8+ T cells by inhibiting their proliferation, thus diminishing immune responses to pathogens and tumor antigens.